Display options
Cite
Ramalingayya GV, Nampoothiri M, Nayak PG, et al. Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks. Pharmacogn Mag. 2016;12:S63-70doi: 10.4103/0973-1296.176104.
Ramalingayya, G. V., Nampoothiri, M., Nayak, P. G., Kishore, A., Shenoy, R. R., Mallikarjuna Rao, C., & Nandakumar, K. (2016). Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks. Pharmacognosy magazine, 12S63-70. https://doi.org/10.4103/0973-1296.176104
Ramalingayya, Grandhi Venkata, et al. "Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks." Pharmacognosy magazine vol. 12 (2016): S63-70. doi: https://doi.org/10.4103/0973-1296.176104
Ramalingayya GV, Nampoothiri M, Nayak PG, Kishore A, Shenoy RR, Mallikarjuna Rao C, Nandakumar K. Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks. Pharmacogn Mag. 2016 Jan;12:S63-70. doi: 10.4103/0973-1296.176104. PMID: 27041861; PMCID: PMC4792002.
Copy Download .nbib Format: NLM
Share it on

Pharmacogn Mag. 2016 Jan;12:S63-70. doi: 10.4103/0973-1296.176104.

Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks.

Pharmacognosy magazine

Grandhi Venkata Ramalingayya, Madhavan Nampoothiri, Pawan G Nayak, Anoop Kishore, Rekha R Shenoy, Chamallamudi Mallikarjuna Rao, Krishnadas Nandakumar

Affiliations

  1. Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India.

PMID: 27041861 PMCID: PMC4792002 DOI: 10.4103/0973-1296.176104

Abstract

BACKGROUND: Cognitive decline or dementia is a debilitating problem of neurological disorders such as Alzheimer's and Parkinson's disease, including special conditions like chemobrain. Dietary flavonoids proved to be efficacious in delaying the incidence of neurodegenerative diseases. Two such flavonoids, naringin (NAR) and rutin (RUT) were reported to have neuroprotective potential with beneficial effects on spatial and emotional memories in particular. However, the efficacy of these flavonoids is poorly understood on episodic memory, which comprises an important form of autobiographical memory.

OBJECTIVE: This study objective is to evaluate NAR and RUT to reverse time-delay-induced long-term and scopolamine-induced short-term episodic memory deficits in Wistar rats.

MATERIALS AND METHODS: We have evaluated both short-term and long-term episodic memory forms using novel object recognition task. Open field paradigm was used to assess locomotor activity for any confounding influence on memory assessment. Donepezil was used as positive control and was effective in both models at 1 mg/kg, i.p.

RESULTS: Animals treated with NAR and RUT at 50 and 100 mg/kg, p.o. spent significantly more time exploring novel object compared to familiar one, whereas control animals spent almost equal time with both objects in choice trial. NAR and RUT dose-dependently increased recognition and discriminative indices in time-induced long-term as well as scopolamine-induced short-term episodic memory deficit models without interfering with the locomotor activity.

CONCLUSION: We conclude that, NAR and RUT averted both short- and long-term episodic memory deficits in Wistar rats, which may be potential interventions for neurodegenerative diseases as well as chemobrain condition.

SUMMARY: Incidence of Alzheimer's disease is increasing globally and the current therapy is only symptomatic. Curative treatment is a major lacuna. NAR and RUT are natural flavonoids proven for their pleiotropic pharmacological effects with potential neuroprotective benefits. The study evaluated these flavonoids for their potential to improve the most common form of episodic memory (memory of autobiographical events in relation to time, places etc.) in two differential animal models assessing short-term and long-term memory, respectively. We also found that NAR and RUT were able to reverse both short-term and long-term memory deficits dose dependently in female Wistar rats. Abbreviations used: AD: Alzheimer's disease, AChE: Acetylcholinesterase, COX: Cyclooxygenase, DI: Discriminative index, ITI: Inter trial interval, NAR: Naringin, RUT: Rutin, NORT: Novel object recognition task, NOS: Nitric oxide synthase, QOL: Quality of life, RI: Recognition index, WFI: Water for injection.

Keywords: Alzheimer's disease; chemobrain; cognition; episodic memory; flavonoids; neurodegenerative disease; novel object recognition task

References

  1. Korean J Physiol Pharmacol. 2009 Aug;13(4):281-5 - PubMed
  2. Nutrients. 2013 Feb 27;5(3):637-50 - PubMed
  3. Biochim Biophys Acta. 2008 Nov;1783(11):2195-206 - PubMed
  4. Biol Pharm Bull. 2011;34(3):360-5 - PubMed
  5. Neurosci Biobehav Rev. 2010 Jul;34(8):1307-50 - PubMed
  6. Br J Nutr. 2010 Oct;104 Suppl 3:S40-7 - PubMed
  7. Eur J Pharmacol. 2009 Aug 15;616(1-3):147-54 - PubMed
  8. Behav Brain Res. 1988 Nov 1;31(1):47-59 - PubMed
  9. J Ethnopharmacol. 2008 Mar 5;116(2):333-40 - PubMed
  10. Neurology. 2007 Nov 13;69(20):1921-30 - PubMed
  11. Cogn Process. 2012 May;13(2):93-110 - PubMed
  12. Evid Based Complement Alternat Med. 2012;2012:930908 - PubMed
  13. J Comp Neurol. 2000 Oct 2;425(4):479-94 - PubMed
  14. J Ethnopharmacol. 2000 Jul;71(1-2):45-53 - PubMed
  15. Neuroscience. 2013 Jan 29;230:157-71 - PubMed
  16. Curr Pharm Des. 2004;10(3):231-51 - PubMed
  17. Chem Soc Rev. 2009 Apr;38(4):1152-61 - PubMed
  18. J Agric Food Chem. 2004 Jul 14;52(14):4414-8 - PubMed
  19. Psychopharmacology (Berl). 1992;109(3):321-30 - PubMed
  20. Nutr Res. 2008 Sep;28(9):629-34 - PubMed
  21. J Alzheimers Dis. 2006;9(3 Suppl):271-6 - PubMed
  22. Clin Neuropharmacol. 2004 May-Jun;27(3):141-9 - PubMed
  23. Brain. 1998 Jul;121 ( Pt 7):1249-56 - PubMed
  24. Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1024-9 - PubMed
  25. Genes Nutr. 2008 Dec;3(3-4):115-26 - PubMed
  26. Science. 2000 Feb 25;287(5457):1433-8 - PubMed
  27. J Pharmacol Sci. 2007 Aug;104(4):329-34 - PubMed
  28. P T. 2010 Apr;35(4):208-11 - PubMed
  29. Brain. 1998 Jul;121 ( Pt 7):1239-48 - PubMed
  30. Genes Nutr. 2007 Dec;2(3):257-73 - PubMed
  31. Brain Res. 2009 Oct 6;1292:123-35 - PubMed
  32. Neurochem Int. 2012 Dec;61(7):1081-93 - PubMed
  33. Brain. 2001 Jan;124(Pt 1):96-102 - PubMed
  34. Alzheimers Dement. 2013 Mar;9(2):208-45 - PubMed
  35. J Med Food. 2010 Aug;13(4):976-84 - PubMed
  36. Physiol Behav. 1995 Mar;57(3):611-3 - PubMed
  37. Cell Mol Neurobiol. 2009 Jun;29(4):523-31 - PubMed
  38. Neuroscience. 2012 May 17;210:340-52 - PubMed
  39. Rev Neurol (Paris). 2008 May;164 Suppl 3:S96-S101 - PubMed
  40. Pharmacol Res. 2003 Dec;48(6):601-6 - PubMed
  41. Indian J Exp Biol. 2014 Jul;52(7):720-7 - PubMed
  42. Neuron. 2003 Jun 19;38(6):987-96 - PubMed
  43. Free Radic Biol Med. 2004 Apr 1;36(7):838-49 - PubMed
  44. Life Sci. 2006 Jan 11;78(7):673-81 - PubMed
  45. Prog Neurobiol. 2011 Dec;95(4):718-28 - PubMed
  46. Proc Nutr Soc. 2010 May;69(2):244-60 - PubMed
  47. Biochem J. 2001 Sep 15;358(Pt 3):547-57 - PubMed
  48. J Neurooncol. 2001 Jan;51(2):159-65 - PubMed
  49. Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33 - PubMed
  50. Clin Pharmacokinet. 2003;42(5):437-59 - PubMed
  51. Int Immunopharmacol. 2011 Oct;11(10):1606-12 - PubMed
  52. Behav Brain Res. 2010 Jan 5;206(1):38-46 - PubMed
  53. Behav Brain Res. 2011 Feb 2;217(1):10-5 - PubMed
  54. Dement Geriatr Cogn Disord. 2004;17(3):151-7 - PubMed
  55. Nature. 2009 Oct 15;461(7266):895-7 - PubMed
  56. Food Chem Toxicol. 2010 Feb;48(2):626-32 - PubMed
  57. Am J Med. 2006 Sep;119(9):751-9 - PubMed
  58. Fitoterapia. 2002 Dec;73(7-8):557-63 - PubMed
  59. Br J Pharmacol. 2006 May;148(2):147-53 - PubMed
  60. J Ethnopharmacol. 2008 Jun 19;118(1):71-8 - PubMed
  61. Molecules. 2007 Sep 03;12(9):2130-9 - PubMed

Publication Types